www.facebook.com/NationalHemophiliaFoundation twitter.com/NHF_hemophilia /stories/feed

Researcher Profiles

By Sarah Aldridge | 04.22.2014

Researcher launched the Pediatric ITP Consortium of North America in 2012.

By Sarah Aldridge | 03.19.2014

Researcher treats pediatric patients with bleeding disorders or blood clots.

By Sarah Aldridge | 02.17.2014

Researcher’s inspiring mentors influenced her career.

By Sarah Aldridge | 09.16.2013

Researcher describes herself as a “people person” who was always interested in science.

By Sarah Aldridge | 07.01.2013

Researcher says fellowship allowed him to focus energy on hemophilia research.

By Sarah Aldridge | 05.15.2013

Researcher divides time between pediatric and young adult patients.

By Sarah Aldridge | 04.11.2013

Researcher always had interest in caring for children.

By Sarah Aldridge | 12.10.2012

Researcher's family physician encouraged him to pursue medicine.

By Sarah Aldridge | 11.14.2012

Researcher has known she wanted to be a doctor since kindergarten.

By Sarah Aldridge | 10.01.2012

Researcher's love for science and kids led to his career in medicine.

By Sarah Aldridge | 09.06.2012

Researcher’s family has three generations of physicians.

By Sarah Aldridge | 08.27.2012

Researcher's interest in hematology started during her residency.

By Sarah Aldridge | 07.19.2012

Researcher began her medical career in nursing.

By Sarah Aldridge | 06.05.2012

Researcher's exposure to medicine started through her physician father.

By Sarah Aldridge | 04.27.2012

Researcher splits her time between clinical research and patient care.

By Sarah Aldridge | 01.10.2011

Researcher used zebrafish to try to identify drugs for bleeding disorders. The fish undergo embryonic development similar to that of humans.

By Sarah Aldridge | 11.29.2010

Dr. Kempton's research focuses on inhibitor development in patients with mild to moderate hemophilia A.

By Sarah Aldridge | 09.30.2010

Dr. Pipe and his team are concerned about making factor VIII product more affordable for the hemophilia community.

By Sarah Aldridge | 09.20.2010

“We have a variety of clinical trials that our center participates in, including looking at prophylaxis in adults and new factor products.”

By Sarah Aldridge | 08.24.2010

Although gene therapy has slowed, Dr. Herzog has confidence in its eventual success. “I think it will be the choice of treatment in the future,” he says.